GEHC Gains 0.70% as Trading Volume Plummets 37% to $300M Ranking 334th in Market Activity

. 9, , ranking 334th in market activity. The mixed performance reflects sector-specific momentum in medical technology amid broader industrial sector caution.

noted the healthcare division’s resilience contrasts with traditional industrial peers, driven by sustained demand for diagnostic imaging systems and digital health solutions. , .

highlighted that GEHC’s performance remains decoupled from parent company exposures, . The divergence underscores sector rotation patterns as investors balance near-term manufacturing cycle risks against long-term healthcare innovation narratives.

To run this back-test accurately I need to pin down a few practical details that aren’t yet specified: 1. Market universe • Do you mean U S-listed equities (e.g. NYSE + NASDAQ), or another market/region? 2. Selection logic • “Top 500 by daily trading volume” – should the list be re-formed every trading day using that day’s volume rank, and each stock be equally weighted? 3. Trade timing • Buy at that day’s open and liquidate at the next day’s open, or buy at today’s close and sell at tomorrow’s close? (Both are common “1-day hold” conventions.) 4. Transaction costs / slippage (if any) • Should we assume zero, or apply a commission/slippage estimate? Let me know your preferences on these points and I can proceed with the data retrieval and back-test.